The Epilepsy Genetics Initiative (EGI) was created by Citizens United for Research in Epilepsy (CURE) to bridge the gap between people with epilepsy, clinicians, and researchers and tailor advances in medical care and decision-making to individual patients.
In this study, CBD would be given in addition to their current anti-seizure medications.
Epilepsy is one of the most common neurological disorders affecting women of childbearing age.
Poor pregnancy outcomes are increased in these women and their children.
This trial, sponsored by the National Institutes of Health and Elekta, the company that manufactures the Gamma Knife, was designed to compare advantages and disadvantages of open surgery versus radiosurgery.
The ROSE Trial (Radiosurgery or Open Surgery for Epilepsy) is in follow-up phase at major epilepsy centers across the US and Canada.